Triclosan: Difference between revisions
No edit summary |
No edit summary |
||
| Line 144: | Line 144: | ||
<!--How Supplied--> | <!--How Supplied--> | ||
|packLabel=[[File:Triclosan 01.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.] | |packLabel=[[File:Triclosan 01.jpg|thumb|none|400px|This image is provided by the National Library of Medicine.]] | ||
[[File:Triclosan 02.png|thumb|none|400px|This image is provided by the National Library of Medicine.] | [[File:Triclosan 02.png|thumb|none|400px|This image is provided by the National Library of Medicine.]] | ||
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label. | |fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label. | ||
| Line 177: | Line 177: | ||
[[Category:Drug]] | [[Category:Drug]] | ||
[[Category:Antibiotics]] | [[Category:Antibiotics]] | ||
[[Category:Antifungals]] | [[Category:Antifungals]] | ||
[[Category:Organochlorides]] | [[Category:Organochlorides]] | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
Revision as of 14:25, 10 March 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Triclosan is an antiseptic that is FDA approved for the treatment of for hand washing to decrease bacteria on skin. Common adverse reactions include hypersensitivity.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- For hand washing to decrease bacteria on skin
- Recommended for repeated use
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Triclosan in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Triclosan in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
- For hand washing to decrease bacteria on skin
- Recommended for repeated use
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Triclosan in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Triclosan in pediatric patients.
Contraindications
There is limited information regarding Triclosan Contraindications in the drug label.
Warnings
- For external use only.
- When using this product avoid contact with eyes. In case of eye contact, flush eyes with water.
- Stop use and ask a doctor if irritation or redness develops, or if condition persists for more than 72 hours.
- Keep out of reach of children.
- If swallowed, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Triclosan in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Triclosan in the drug label.
Drug Interactions
There is limited information regarding Triclosan Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Triclosan in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Triclosan during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Triclosan with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Triclosan with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Triclosan with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Triclosan with respect to specific gender populations.
Race
There is no FDA guidance on the use of Triclosan with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Triclosan in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Triclosan in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Triclosan in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Triclosan in patients who are immunocompromised.
Administration and Monitoring
Administration
Monitoring
There is limited information regarding Monitoring of Triclosan in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Triclosan in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Triclosan in the drug label.
Pharmacology
Template:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox E numberTemplate:Chembox AppearanceTemplate:Chembox DensityTemplate:Chembox MeltingPtTemplate:Chembox BoilingPtTemplate:Chembox NFPATemplate:Chembox FlashPtTemplate:Chembox Supplement| Template:Chembox header2 | Triclosan | |
|---|---|
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
| KEGG | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C12H7Cl3O2 | |
| Molar mass | 289.54 g·mol−1 |
| Hazards | |
| Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
Mechanism of Action
- At high concentrations, triclosan acts as a biocide with multiple cytoplasmic and membrane targets.[1] However, at the lower concentrations seen in commercial products, triclosan appears bacteriostatic, and it targets bacteria primarily by inhibiting fatty acid synthesis.
- Triclosan binds to bacterial enoyl-acyl carrier protein reductase (ENR) enzyme, which is encoded by the gene FabI. This binding increases the enzyme's affinity for nicotinamide adenine dinucleotide (NAD+). This results in the formation of a stable, ternary complex of ENR-NAD+-triclosan, which is unable to participate in fatty acid synthesis. Fatty acids are necessary for building and reproducing cell membranes. Humans do not have an ENR enzyme and thus are not affected.
Structure
There is limited information regarding Triclosan Structure in the drug label.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Triclosan in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Triclosan in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Triclosan in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Triclosan in the drug label.
How Supplied
There is limited information regarding Triclosan How Supplied in the drug label.
Storage
There is limited information regarding Triclosan Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Triclosan |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Triclosan |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Triclosan in the drug label.
Precautions with Alcohol
- Alcohol-Triclosan interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ANTIBACTERIAL SPRAY®[2]
Look-Alike Drug Names
There is limited information regarding Triclosan Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Russell AD (2004). "Whither triclosan?". J Antimicrob Chemother. 53 (5): 693–5. doi:10.1093/jac/dkh171. PMID 15073159. Check
|pmid=value (help). - ↑ "ANTIBACTERIAL SPRAY - triclosan liquid".
{{#subobject:
|Label Page=Triclosan |Label Name=Triclosan 01.jpg
}}
{{#subobject:
|Label Page=Triclosan |Label Name=Triclosan 02.png
}}